{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/epa/cases/check?name=Pharmacia%20%26%20Upjohn%20S.P.A.","name":"Pharmacia & Upjohn S.P.A.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://echo.epa.gov/tools/data-downloads/icis-fec-download-summary","generated_at":"2026-10-05T19:42:28.978Z"},"summary":{"total_cases":1,"total_penalty_assessed_usd":0,"total_cost_recovery_usd":0},"cases":[{"activity_id":"88884","case_number":"02-2003-0001","case_name":"Berlex Laboratories, Inc. et. al.","fiscal_year":2003,"activity_type_desc":"Judicial","enf_outcome_desc":"Final Order With Specified Cost Recovery","total_penalty_assessed":null,"state_code":null,"defendant_name":"Pharmacia & Upjohn S.P.A.","named_in_complaint":"Y","named_in_settlement":"Y","canonical_url":"https://api.morvs.ai/epa-case/88884"}]}